Xiao X, Li J, Samulski R J
Gene Therapy Center, University of North Carolina at Chapel Hill, 27599, USA.
J Virol. 1996 Nov;70(11):8098-108. doi: 10.1128/JVI.70.11.8098-8108.1996.
Muscle-directed gene transfer is being considered for the treatment of several metabolic diseases, including hemophilia and Duchene's muscular dystrophy. Previous efforts to target this tissue for somatic delivery with various vector systems have resulted in transient expression due to silencing of the transgene or to an immune response against the vector-transduced cells. We introduced recombinant adeno-associated virus vector (rAAV) carrying a lacZ reporter into muscle tissue of immunocompetent mice. The lacZ reporter gene was efficiently transduced and expressed with no evidence of a cellular immune response. Moreover, gene expression persisted for more than 1.5 years. Molecular characterization of rAAV vector DNA suggests a mechanism for persistence, since vector episomes convert to high-molecular-weight genomic DNA. These data provide the first report for establishing long-term gene transduction into mammalian muscle cells in vivo without the need for immune modulation of the organism.
肌肉定向基因转移正被考虑用于治疗多种代谢性疾病,包括血友病和杜氏肌营养不良症。此前利用各种载体系统将基因导入该组织进行体细胞递送的努力,由于转基因沉默或针对载体转导细胞的免疫反应,导致基因短暂表达。我们将携带lacZ报告基因的重组腺相关病毒载体(rAAV)导入具有免疫活性的小鼠肌肉组织。lacZ报告基因被高效转导并表达,且没有细胞免疫反应的迹象。此外,基因表达持续超过1.5年。rAAV载体DNA的分子特征提示了一种持续存在的机制,因为载体附加体可转化为高分子量基因组DNA。这些数据首次报道了在无需对机体进行免疫调节的情况下,在体内实现向哺乳动物肌肉细胞的长期基因转导。